AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2015
Feb 19, 2015
32939_dirs_2015-02-19_d7e5e545-205f-484b-bea4-d2e5f6b8350f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2015-02-13
Reporting Person: Richard Stark (SVP, GM - Oncology)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-13 | Common Stock | M | 18100 | $15.27 | Acquired | 46801 | Direct |
| 2015-02-13 | Common Stock | S | 18100 | $18.53 | Disposed | 28701 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-13 | Non-Qualified Stock Option (right to buy) | $15.27 | M | 18100 | Disposed | 2015-08-06 | Common Stock (18100) | Direct |
Footnotes
F1: Options for 25% of the shares each became exercisable on 08/06/2009, 08/06/2010, 08/06/2011 and 08/06/2012, respectively.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6